NewG Lab Pharma (NGLP) is a Baltimore-based pharmaceutical company dedicated to developing innovative metabolic anti-cancer therapeutics that aim to extend the lifespan of cancer patients while maintaining their quality of life.
With a focus on whole-body metabolism rather than tumor reduction alone, NGLP recognizes the limited correlation between overall survival benefits and tumor size. By addressing the prime cause of cancer, which is the replacement of oxygen respiration with sugar fermentation in normal body cells, NGLP aims to combat cancer as a mitochondrial dysfunction.
Generated from the website